chrisvoncsefalvay/vaers-outcomes huggingface dataset:
the consumer experienced inflamed lymph nodes in the axilla area of the arm that was injected (left arm).; This is a spontaneous report from a non-contactable consumer (patient) via Pfizer Sales Representative.  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number: not provided), via an unspecified route of administration on the left arm on unknown date at SINGLE DOSE for COVID-19 immunization. It was reported that the patient was a cancer survivor. The patient's concomitant medications were not reported.  On an unknown date shortly after receiving the vaccine, the patient experienced inflamed lymph nodes in the axilla area of the arm that was injected (left arm). Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Pain in neck and back on right side; Pain in neck and back on right side; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 28Sep2023 at 17:00 as dose number unknown, single (Batch/Lot number: unknown) at the age of 52 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Thyroid cancer" (unspecified if ongoing), notes: other medical history: Thyroid cancer; "known allergies: Sulfa" (unspecified if ongoing), notes: known allergies: Sulfa. Concomitant medication(s) included: TYLENOL. The following information was reported: NECK PAIN (non-serious), BACK PAIN (non-serious) all with onset 29Sep2023, outcome "recovering" and all described as "Pain in neck and back on right side". Therapeutic measures were taken as a result of neck pain, back pain. Additional information: Patient did not receive any other vaccine in four weeks. Other medications received in two weeks were Tylenol and multi vitamins. Patient did not have covid-19 prior to vaccination and was not tested for covid post vaccination. Patient took Tylenol and drank water as treatment for events.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
On May 10th i started to feel dizzy while laying down with my son.   Since then it has been weird head sensations (light headed, brain fog, feelings of me moving when I am not) combined with terrible sinue pressure and pain, sinus headaches and facial pain
Information has been received from a physician concerning a patient who on 17-MAR-2008 was inadvertently vaccinated with VARIVAX (Oka/Merck) instead of ZOSTAVAX (Oka/Merck). There was no product confusion involved; the incident was due to human error. The patient did not experienced any know symptoms. At the time of the report the patient's status was unknown. There was no product quality complaint involved. Follow-up information from the pharmacist indicated that the patient did not develop any adverse symptoms. Additional information has been requested.
Pain right underarm area; Severe headache; swelling in right underarm area; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 25Mar2021 at 15:15 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and did not receive any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: unknown) via an unspecified route of administration in the left arm on 04Mar2021 at 15:15 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Mar2021, the patient had undergone nasal swab test for COVID-19 and the result was negative. On 26Mar2021 at 17:30, the patient experienced pain and swelling in right underarm area and severe headache. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events pain and swelling in right underarm area and severe headache. The clinical outcomes of the events pain and swelling in right underarm area and severe headache were not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Neuropathy type sensation in feet, lower legs, hands; difficulty breathing; tongue felt tingly and swollen; raised red itchy rash on neck, chest and abdomen; swollen lymph glands in throat; diarrhea; sore throat; site soreness; achy joints; headache; nausea; fatigue; Racing heartbeat; throat felt lujeir was closing; tongue felt tingly and swollen; This is a spontaneous report from a contactable healthcare professional (the patient). A 66-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EN6205), via an unknown route of administration in the left arm on 06Mar2021 at 16:30 (at the age of 66-years-old) as a single dose for Covid-19 immunization. Medical history was included celiac sprue, Crohns, chronic pancreatitis, psoriasis, osteoporosis, and ulcerative colitis, all from an unknown date and unknown if ongoing. The patient was allergic to penicillin and codeine. The patient previously received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EL9269) on 13Feb2021 at 11:30 in the left arm. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported however it was reported the patient had other medications in two weeks. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Mar2021 at 16:30, within 5 minutes of injection, the patient experienced Racing heartbeat, difficulty breathing, tongue felt tingly and swollen, throat felt lujeir was closing, and neuropathy type sensation in feet, lower legs, hands. The patient also experienced the typical side effects of site soreness, achy joints, headache, fatigue, nausea, sore throat, diarrhea, swollen lymph glands in throat, and raised red itchy rash on neck, chest and abdomen. Treatment of Benadryl was given for the events as recommended by paramedic which was still being taken on day 4. The clinical outcome of the events racing heartbeat, difficulty breathing, tongue felt tingly and swollen, throat felt lujeir was closing, and neuropathy type sensation in feet, lower legs, hands was recovered on 06Mar2021 (reported as 'last about 10 minutes'); outcome of site soreness, achy joints, headache, fatigue, nausea, sore throat, diarrhea, swollen lymph glands in throat and raised red itchy rash on neck, chest and abdomen was not recovered. It was reported that since the vaccination, the patient had not been tested for COVID-19.; Sender's Comments: Based on chronological connection to the vaccine a causal relationship between reported events and BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Began having numbness and nerve pain in right foot, progressed up right leg and began in left leg until 1/30/2014 in which I acquired bilateral paralysis of my legs and was unable to walk.  I was admitted to the hospital and diagnosed with Transverse Myelitis.
A 10-year-old patient was administered an adult dose of the COVID-19 Pfizer vaccine.
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport  refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
FLU-LIKE SYMPTOM DAY AFTER THE VACCINE. IT LASTED 1 DAY.
Left arm will swelling, redness, warm to the touch; there is a 3 1/2 by  1/2 area inflamed, induration, tender to touch with axillary nodes.
redness presenting a couple of inches below the injection site; This case was reported by a pharmacist and described the occurrence of erythema in a 92-year-old female patient who received Herpes zoster (Shingrix) (batch number 9H3Z4, expiry date 27th August 2022) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknkown date).   On 26th January 2021, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. In January 2021, less than a week after receiving Shingrix, the patient experienced erythema. On an unknown date, the outcome of the erythema was not recovered/not resolved.   It was unknown if the reporter considered the erythema to be related to Shingrix.  Additional details were provided as follows: The patient received her dose in left arm and experienced redness presenting a couple of inches below the injection site. The information regarding consent to follow was not reported. No further information was available.
pt recv vax; inc fussiness & mild T; following vax cont to exhibit fussiness & dec appetite through the noc;presented to ofc; tx conservatively; apap & watch; resolved w/in 36 hr;
No adverse event; given a 0.25mL dose of the bivalent vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (given a 0.25mL dose of the bivalent vaccine) and NO ADVERSE EVENT (No adverse event) in an 83-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 053D22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 14-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .25 milliliter. On 14-Oct-2022, the patient experienced ACCIDENTAL UNDERDOSE (given a 0.25mL dose of the bivalent vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (given a 0.25mL dose of the bivalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (given a 0.25mL dose of the bivalent vaccine).    No concomitant medications were reported. No symptoms were reported. No additional doses given were reported. Patient did not receive any treatment.
Information has been received from a nurse practitioner concerning a patient who was vaccinated SC with a 0.5ml dose of varicella virus vaccine live. There was no concomitant medication. The child presented to the clinic with a rash following vaccination. No treatment was required. It was noted that the vaccine was given elsewhere and that the reporter did not want to give any detailed information and commented that this happens (all the time). Unspecified medical attention was sought. There was no product quality complaint involved. No further information has been requested.
has severe rash has progressed to blisters, much worse, blisters on hands also , diffuse rash
back pain upper mid back, spread to left & right side; lower back muscles on the left & right side; This is a spontaneous report from a contactable healthcare professional. A 55-year-old female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EK5730) on her right arm, via an unspecified route of administration on 23Dec2020 10:00 at a single dose for covid-19 immunization. Medical history included hypertension (HTN), asthma, obesity, postmenopause, hay fever, pre diabetic and allergy to sulfa. Concomitant medication included chlorthalidone, carvedilol (COREG), fexofenadine hydrochloride (ALLEGRA) and phytomenadione (VITAMIN K). The patient experienced back pain upper mid back, spread to left & right side and lower back muscles on the left & right side.; both on 03Jan2021 11:00 AM. The patient received lidocaine, methacarbamol, T3, prednisolone dosepak as treatment for the events. The outcome of the events was recovering.
8hrs after taking the vaccine she had very severe burning in her vagina area. Right temp pain. 12hrs later she started getting a stiffing and swelling pain on her back. She became weak where she could not hold her top body up.  Lost some rectal function. The burning kept going down her thighs and severe pain like she is about to start her menstrual.
7 days post vaccine onset of fatigue, left axillary lymph node enlargement and soreness, left lung irritation, sore throat, chills, body aches lasting for 10 days. No fever. Covid testing negative on 1/8. Continued left axillary lymph node soreness and swelling currently.  Other symptoms have subsided.
Breakthrough case admission after two vaccines MOderna 4/19/21 Lot# 043B21A;  Moderna 12/9/21 Lot# 030H21B
Pt experienced rash on chest and face/scalp on 2/27/01 and complained of itchiness and redness, especially on face and scalp. States this lasted about 2 weeks after onset of symptoms on 2/27/01. States she had another bout of facial rash on 3/17/01. (Pt also exposed to chemicals at work site on the same date of 2/26/01).
I am a doctor and have never had any reactions to any vaccinations.  About 8 hours after a TDAP booster (I also had a TDAP in 2006) I developed a severe headache and serum sickness-like reaction, lasted 48 hours.  I was too sick to work for 2 days, and I never miss work.
I started developing a frozen shoulder in my left shoulder. I saw my GP for it. I recognized the symptoms because I had had a frozen shoulder in my right shoulder previously. He referred me to a  physical therapist, still having physical therapy sessions and to an orthopedist, he asked me which arm I had the vaccine. I had the first one in my right arm and the second one in the left arm. Have been in physical therapy since May. It was originally three times a week and then down to two times a week and back to 3 times a week now. It's getting worse. With the orthopedist, he just recommended the physical therapy because I am allergic to the steroid shots.
This spontaneous report as received from a pharmacy technician refers to a patient of unknown date. The patient was vaccinated with the first dose of VARIVAX (merck) in 1998 and the second dose on 16-NOV-2012. No other co-suspects were reported. No concomitant medications were reported. No adverse event was reported. No other information to report. Additional information is not expected.
Varicella vaccine breakthrough. Had vaccine 6-2-00 and 8-17-07. Diagnosed with varicella 11-7-07
Vaccine administered on 8/8/02.  Woke the next morning with warm, hard, painful area at site of injection.  No systemic effects.
Myalgia, Fever, Tachypnea, Palpitations, Tachycardia, Sweats & chills, panic attack with numb arms, twitching eyes/mouth. Exhausted x 2 days Narrative:  2nd dose on 7 Jan @1015 1028 Felt hot. (? Heaters on high) Flushed, sweating. Nurse agreed it was hot, took her to back. Light headed. Shaky weak. Cooled down outside. Ice water & ice pack Didn't feel able to walk by self, lay down. Called team. Symptoms tachycardic. Tachypneic with numb arms, twitching eyes and mouth. 124/80 O2 sat ok. 1145 back to office, exhausted. o/w ok. Slept day and next day. Hot flashes next two days myalgia. By Saturday back to normal. Injection site was very sore
Approximately 5 minutes after receiving the vaccine, the patient lost consciousness. She awoke after a few seconds. Her father declined emergency services. She remained in the pharmacy for 15-20 minutes and was monitored. She then left with her father.
Her finger nails on the left hand are slightly blue; Headache; This is a spontaneous report from a contactable consumer (patient brother). A 23-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration on 19May2021 (at the age of 23-years-old) (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. The patient medical history was not reported. There were no concomitant medications. The patient received the Pfizer covid vaccine on 19May2021 and experienced headache and her finger nails on the left hand are slightly blue. The patient had the headache which was normal. Caller reported that today, 20May2021, the patient's fingernails on her left side were slightly blue. Caller wanted to know what do regarding that. Caller stated that he did not know exactly what they need to do. Caller inquired if that was something he needed to take his sister in for. Caller reported that he talked to a relative who suggested that he contact Pfizer. Caller inquired if Pfizer has had any reports of blue fingernails following the Covid-19 vaccine. Caller stated that he wanted to speak in the event that the patient needed to seek urgent medical attention. Outcome of the events was unknown.  Follow-up (05Jul2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Slept most of the day; Vaccination site pain; threw up; Headache; gave a shot of the Moderna first shot to a 16 year old patient; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (gave a shot of the Moderna first shot to a 16 year old patient), SOMNOLENCE (Slept most of the day), HEADACHE (Headache), VACCINATION SITE PAIN (Vaccination site pain) and VOMITING (threw up) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Oct-2021 at 11:10 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Oct-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (gave a shot of the Moderna first shot to a 16 year old patient) and HEADACHE (Headache). On 28-Oct-2021, the patient experienced SOMNOLENCE (Slept most of the day), VACCINATION SITE PAIN (Vaccination site pain) and VOMITING (threw up). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. On 27-Oct-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (gave a shot of the Moderna first shot to a 16 year old patient) had resolved. On 29-Oct-2021, SOMNOLENCE (Slept most of the day), HEADACHE (Headache), VACCINATION SITE PAIN (Vaccination site pain) and VOMITING (threw up) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered SOMNOLENCE (Slept most of the day), HEADACHE (Headache), VACCINATION SITE PAIN (Vaccination site pain) and VOMITING (threw up) to be possibly related. No further causality assessment was provided for PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (gave a shot of the Moderna first shot to a 16 year old patient).    Concomitant product use was not provided by the reporter. The patient had no allergies. The patient had never been diagnosed with COVID-19. The patient had no acute illness at the time of vaccination and up to one month before. The patient had no chronic or long-standing health conditions. No prescriptions, over-the-counter medications, dietary supplements, or herbal remedies were taken at the time of vaccination.   Most recent FOLLOW-UP information incorporated above includes: On 29-Oct-2021: Follow-up contains additional events, updated patient demographics, vaccination start time, anatomical location, action taken and treatment product.
pt recv vax 9MAY95 & 540PM returned a call stating pt limp, pale & becoming cyanotic; pt spontaneously resumed breathing 15-30seconds & gradually returned to nl w/nl exam;
About ten days after vaccination, hives began to show up on my lower abdomen . Since then, hives appeared in many areas of my body as well as itching where there are no hives. My eyes are also itchy. The hives and itching become worse when my body heats up during exercise or when covered by warm clothing or blankets.  I'm taking 2 Benadryl every six hours, which provides relief but not entirely. This has been going on for 9 days now. I eliminated eggs and Teeccino Dandelion Dark Roast from my diet several days ago and cut my probiotic dosage in half, thinking these might be the culprits, but so far I continue to itch and have hives.
Swelling of upper arm and shoulder on the night and day after vax.  Second day after vax, chills, nausea/vomiting and fever of 100.6.
2/16/2020:EVENING:  PT FELT CONFUSED.  2/17/2020: EVENING- PT FELT BURNING PAIN, NUMBNESS, OCCASIONAL SHARP STABBING PAIN IN LEFT CHEST AREA, BREAST AND NIPPLE, LEFT ARM AND LEFT UPPER BACK AREA.  ARM FEELS HEAVY.  RANGE OF MOTION IN LEFT SHOULDER WAS NOT AFFECTED.  PT WENT TO E.D. 2/20/20 FOR EVALUATION. PT STATES HEART ATTACK AND SHINGLES WAS RULED OUT.
Moderna COVID-19 Vaccine EUA - Swollen and tender lymph node in armpit of same arm of injection
Information has been received from a physician concerning a female patient who on an unknown date was vaccinated with a first 0.5 ml dose of GARDASIL (Lot No. not reported). On an unknown date the patient developed rash on the face and neck area. The patient sought unspecified medical attention. On an unknown date the patient recovered. Additional information has been requested.
My son in law tested positive for COVID 19 and I had been with him over the weekend so I completed an on go antigen. I never developed any symptoms. I was advised to quarantine for 5 days and I have recovered.
Redness and swelling of right upper arm. complained of itching in the affected arm. systematic care with Benadryl.
Diarrhea & vomiting for about 2 to 3 hrs total.